NCT06179199View on ClinicalTrials.gov

Evaluation of the Analgesic Effect of Transcranial Direct Current Stimulation (tDCS) for Sedated Patients in Intensive Care Unit.

NANot yet recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
Transcranial Direct Current Stimulation (tDCS)
Interventions
DEVICE

SOOMA™ tDCS™

The SOOMA™ tDCS™ device is designed to treat chronic pain, with a stimulation current of 2milliampere and a duration of 20 minutes

Trial Locations (1)

Unknown

Pain Management Center - Chuga, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT06179199 - Evaluation of the Analgesic Effect of Transcranial Direct Current Stimulation (tDCS) for Sedated Patients in Intensive Care Unit. | Biotech Hunter | Biotech Hunter